Player is loading...
GenePOC, a breakthrough solution in molecular point-of-care testing
Patrice Allibert, GenePOC
Thursday, Oct. 26, 2017 · 11:19 a.m. · 27m 52s
Embed
Transcriptions
Note: this content has been automatically generated.
00:00:00
the sanitation and giving me the opportunity to uh open the
00:00:04
door and uh show what's behind the jane part
00:00:09
so let's begin by uh once upon a time like that uh something to make c. d.'s name is
00:00:15
michelle there's a hole in two thousand seven one in from the the the gene part and
00:00:21
michelle is opinion yeah of uh the infectious disease molecular diagnostic he's the one who launched the first
00:00:27
uh that is even resistance staff has matured agnostic you should just testing and compromising testing
00:00:34
and they say that when you create a the during part people lasting like
00:00:39
mean gene part one two seven seven it's only ten years ago of
00:00:43
people it's only said that you thought i mean gene one of k. people
00:00:47
laughing because said that molecular there to speak never the point of k.
00:00:53
and uh you should notice and everything uh so this is now
00:00:57
the reality and we have to make an example of
00:01:00
a disruptive technology that has been your a lot of people at the beginning so we just then quickly some
00:01:08
remember kodak one for a big budgeted for that big pain
00:01:12
and go back say never would overtake the feeling like barrett of phone was out the keyboard
00:01:19
we never worked or not yeah with people just want the good phone not the internet
00:01:27
but this one is long this one is close to and then this one is gone
00:01:32
so you cannot read can refuse a breakthrough technology disruptive technology when it's coming
00:01:39
you have really to analyse the value of the technology is he the best way to include
00:01:43
that in your day to day activities so this is the same was molecular biology
00:01:48
so we we ah the next revolution in molecular biology because of the technology we present
00:01:54
is that okay with you through the system machine and with with jean
00:01:59
this is our instrument and the for the one who nor
00:02:03
of a molecular biology in the uh late eighties
00:02:08
remember that that that time and we want to implement a mercury
00:02:11
lebanon or split or you have to go with three rooms
00:02:15
was about hundred square meters and today what you have done was
00:02:19
their budget would bring that a hundred square meters between eight
00:02:23
something that that's good or something but yes but it's on the display so this is really a good one
00:02:29
say you tonight we never know what will happen instance somebody will come use move yeah it more
00:02:35
with action most uh the mean that users on the the technology but i think we have done the
00:02:40
vaguely uh a very big step how does it work now or why we do need part
00:02:47
more today than yesterday and more to more again than today
00:02:52
let's see what's happened with the patient coming into they must be taught patient is omitted from infection
00:02:59
but most of the time sample are collected and the tests are sent to the uh the lab
00:03:06
the lab can be inside your speed thought but more and more the lab is not anymore
00:03:11
in the hospital doesn't recession the flap in town in countries also so there's a reduction
00:03:19
in the past or we will only to send a sample from the patient
00:03:25
the lab it takes when it's inside because people four to six hours
00:03:31
when there is a subset is action of the lab to take to turn the
00:03:34
sample from the patient to the lab you take a who's eighteen hours
00:03:39
so with the patient for example having sepsis you can imagine the
00:03:43
disaster that can happen because the clock is a big clark
00:03:46
so the test will be powerful one two three days until you have to find an answer and then you can
00:03:52
really have a good idea how to initiate the treatment and we consider the else how come they get it
00:04:00
which point of care so that mean that you move the technology or the testing closer to the patient
00:04:06
you can see that the clock is much much smaller we're speaking hours and the base
00:04:12
reception of the that the stick result is about an hour in addition initiation of the treatment again in an
00:04:18
hour and they have a health outcomes much of much better than what the different between the two
00:04:26
is for the disease which speak about laughter is the the risk of transmission
00:04:31
until you do not have isolate the patient buys the patient would continue to this in a uh the disease
00:04:37
which is a good example was to see them the t. seal and morbidity and mortality will increase
00:04:43
so this is as wide today i've seen the point of can uh oh what to
00:04:49
name your patient testing beginning can impact has been demonstrated yeah tones of studies
00:04:55
to show in the most uh that if you perform the task very quickly and if you can have
00:04:59
an actionable with that for the patient that is uh uh with the uh very strong added value
00:05:06
so we all know that the hester cost uh is permanently increasing every window along
00:05:12
for me recently see after so this is why we have this something business on the flop again
00:05:18
this is all over the world of canada and the us in france in all countries
00:05:22
this is what i said the change is is ongoing so we cannot
00:05:26
stop it unfortunately the something is action is not the right answer
00:05:31
for infectious disease because we need a quick action that could decision
00:05:36
uh i was every hour we lose in the sepsis the risk
00:05:41
of by a best of the patient is significantly increasing
00:05:44
so the only way to answer that is to the central or something
00:05:48
i think not or but sometimes think back to the lab
00:05:51
and that must be done under the supervision of the lab or with the metadata just
00:05:57
and their need would never stop increase from any reason population just page is increasing so we
00:06:04
see more and more that the the need to perform some testing in retirement home
00:06:08
mainly uh one we haven't we know is that shouldn't be p. c. and
00:06:12
have also has got to be a testing that should be done
00:06:17
and any ah and we talked about the regular basis you expect that every two hours days of below new one
00:06:23
so it all as it uh and then then the the next one but that would count just be patient
00:06:29
and there is uh what would but only what i call our nuclear bomb
00:06:34
expose monday the problems not even just one when is the multi resistant but that i
00:06:39
will not under the door and we see that also all over the world
00:06:43
and the the we must to find the best way to block them twice a also either the patient
00:06:50
so a part as it is the abbreviation it is for me or we use
00:06:56
every time there's something with single pass people call that apartment of k.
00:07:01
so what means papa not part of the people so we can refer to but that which will
00:07:06
definition this is the one they're using when they go to want to go under and uh sell some tests in the rubbing country
00:07:13
uh that's a call that i show up for the board
00:07:15
sensitive specific user friendly rapid rubbers to keep and free
00:07:20
unfortunately for molecular biology cannot be equipment free because you need
00:07:24
to provide a tool to on the molecular uh the the amplification it whatever it is i
00:07:29
will turn work or a p. c. i. and also that about the fun results
00:07:34
but isn't that one also will need to address saying
00:07:39
what means in infectious this input after testing
00:07:43
this isn't actions diagnostic testing that is performed outside the clinical laboratory
00:07:49
that i mean not under the micro vigil the microbiology um a ladder
00:07:55
because the control must be there but the person running the test must
00:07:59
not be inside the microbiology lab can be decent rise another lab
00:08:03
so this is also an important point this is why we need connectivity between the
00:08:08
instrument and the lab and then the microbiologist and always ready the the result
00:08:13
another point that has been said before it's not because in point of care that the
00:08:18
performance of the test must be low when than any other tested of liquor performance
00:08:23
must be at least it not to cut to the want octane in the large law oh
00:08:27
with the big system in the every large level of the uh central as that
00:08:34
project but what the right answer for the molecular during the sick part of
00:08:37
care so we combine in our for an instrument record rubber jean
00:08:43
so this instrument is unit is uh one is flexible you
00:08:47
can want want to example at the same time
00:08:51
i can be different sample because today we have only one protocol
00:08:55
or the test or running on his d. n. a.
00:08:58
uh it takes seventy minutes seven zero to run the the eight or the one sample
00:09:04
put it that made it is uh the sample to loading is only one minute order is where is it
00:09:09
cost effective this is part of the whole the launch so before the pathetic the that's every combat on that after
00:09:16
connectivity ski so the system is bidirectional connectivity with the major stand
00:09:21
up to the you including part i want a small footprint
00:09:26
that's the size of a espresso machine michelle is putting that in the space of the in a so you can uh an idea
00:09:34
so it's uh it's about the same size uh there's a nothing like and one
00:09:38
and the if you want to really come printer you can do that but the what's important is a computer is on both
00:09:45
user friendly with a simple set that it takes about not more than five minutes to train
00:09:50
a new user with the system because the interface is very intuitive is like my phone
00:09:56
and for the one one of the us it's what what we call yeah we're compatible
00:10:01
could be yeah where is the certification in the us that mean that everybody you know most people can perform the test
00:10:08
so we are we are not seventy five feet away but the discussion with the da told us that uh we could go the if we want
00:10:15
in front of that we have is a small piece of plastic surgery imagine just uh
00:10:20
the the size athlete the part the gene park project concept with the c. d.
00:10:25
so this evening was studied in a different part the part was prototype kuwait recorded the
00:10:31
part so it's one eight of the size of a c. d. at the beginning
00:10:35
so in this small piece of uh plastic uh we can deliver the menu and they have
00:10:42
a actually i loved it and thank y. infection shaken features easy isn't sexually transmitted infection
00:10:49
this is done he also have the power to detect reason you won a disposable written that that up
00:10:54
to twelve target so we can work and that that call me nippon they're not allowed to want
00:11:00
we don't want to go there but the mini panel really morning tradition for example not
00:11:04
very fun that almost got away panel over budget is on them that uh
00:11:08
provide the right answer the on set about trying to find the take the and
00:11:11
then there are the type that we can also the remote onto that result
00:11:16
and this is important also that a small cap size
00:11:20
and because a significant people's a lot of time
00:11:24
we know that in the class about the significant part of the course is going to the waist
00:11:30
so we are really if you compose competition about one sixth of the weight and the the size so
00:11:36
this is a significant also reduction in the cost so this is again part of the cost effectiveness
00:11:43
so the way it works really begin with the sample uh usually to swab
00:11:48
or receive example with the first and if you see so lucas tool
00:11:53
that with the shops in the small tool that we provide supper buffet show
00:11:57
which ones find the pile of volume between a hundred and two hundred like to do that we don't need to be precise
00:12:03
the system after the and my my coffee they couldn't manage by itself uh the bottle
00:12:09
then we place on the water and the machine after a running quarterback for the notification place inside
00:12:16
the machine and one start and after that i went and you need to have the results
00:12:22
hands on time you can see is really limited is very quick on the two one minute
00:12:27
so the power of the pie had as it works much the nation but
00:12:31
that so this is a size and this is divided in three section
00:12:35
the first one is what you call the road in section where we put our hand with two hundred mike that either the sample
00:12:42
then we have a universal sample clap here i come back on that and then
00:12:46
we'll the p. c. amplification with the tree wells one two three which other
00:12:50
so again we packed our sample transfer to the to transfer to the pile
00:12:55
and then when we put on and one on the machine just thought immediately machine will spin
00:13:02
never stops spinning during the seventy minutes so the movement of liquid is
00:13:07
done by spin and also we use a different level of temperature
00:13:12
open across some uh some uh choose inside that to uh
00:13:15
to move the liquid so the the liquid moving aside
00:13:19
a small chandler hey we call homage invention channel but on this is which
00:13:24
you spoke about the uh sample prep which is a key aspect
00:13:28
the sample pack is not only lies in the back of a a purifying the
00:13:32
d. n. a. the supper prep is also working on the sample itself
00:13:36
when we were visible journals while we have a lot of makers and
00:13:40
like this is not the best a friend with p. c. o.
00:13:44
and when we work with his tool we have pieces of two and still is not
00:13:47
also the best one was busy at some point you're the most innovative a sample
00:13:52
so in this region essential amber when have some glass be then shaking which is done by the military
00:13:57
this well imagine as a sample at the end is no more less whatever that we have
00:14:02
then by something vacation remove the liquid in this chandler via
00:14:07
where we have a small too which is close by lifting blue we hate that section not ninety five degrees
00:14:14
i'm not that if i did we lies the back what about these no one that would resist
00:14:20
and we also uh open but you and that you will give you the
00:14:24
sample and put it in the right conditions for the p. c. off
00:14:27
yeah we're sort of a a small additional aspect which is the process control our process controls as well
00:14:34
that's the cities so if we can license for buses to t. v.s you can like everything
00:14:40
so down the peace yeah we re transfer young person to gauge and the body in the
00:14:45
in the three p. c. awareness and then the machine is equipped reach for the eyes
00:14:50
so with one by reaching the take up to four o. eight or twelve time
00:14:56
but for the test i will give my uh more information after we use only
00:15:01
one where um but we can feed the tree was depending on the type
00:15:05
so the train example no the first one will be with us would be strap
00:15:10
it's a test that says perform a different stage usually a for pregnant women
00:15:15
and she has to go for the testing to be done the thirty five weeks of pregnancy
00:15:20
and means about five to seven years before that every and uh if the taxes positive at the
00:15:26
time of the very the room and will receive a shot of an antibiotic of beneath it
00:15:31
unfortunately i had about thirty percent of the women that that change the status
00:15:37
was it a will become negative a negative will become positive so the
00:15:41
value of this task the form of the minus five weeks
00:15:45
as we know them strong value and this is why we have no another test
00:15:50
which is called d. s. also directs well that must be it can be and must be perform at the time of the river
00:15:57
so we have this to test and again this is the same we begin with the sample is either culture
00:16:02
up to thirty five weeks are the occasional actors well the time of the rate
00:16:07
that would be shy wasn't you put out here and then we won and machine one of the most of it
00:16:13
so this is the the performance we have today uh with g. b. s. l. b.
00:16:18
so we have a very good and very uh a very good sensitivity and specificity
00:16:25
most of the sample we mixed is not that we need the caption miss them
00:16:30
and every every time we will be checking if the to the sample we would missing
00:16:34
with another a nucleic uh application technology we always find them positive for the
00:16:41
problem of the g. d. s. testing you know the p. c. r.
00:16:45
the value and the quality of the person who will be the plate uh with the d. b. s. because it's not the in either way
00:16:52
uh with the the yes we have the same will ever have very high sensitivity
00:16:56
and the specificity was due to this uh the sample that again we found positive with d. n.
00:17:02
a. the d. n. a. is here so the buddies here but unfortunately it was nice
00:17:06
put it by the capture the the dean so amazing to see
00:17:11
that uh yeah when michelle there's a whole presented the first
00:17:15
time to sound on the g. d. s. test the a. d. a. that was the first time the baby a switch
00:17:21
and said no there is no more testing with microbiology you can go directly with
00:17:25
the p. c. amplification for the result of that was the first time
00:17:30
so the performance over very good really run the test uh uh during the last months in germany
00:17:36
and then the final result in the lab we were close to a ninety ninety eight
00:17:41
percent of our sensitivity and specificity in real life also because we are there
00:17:47
said if that's an also said if a is a test
00:17:51
that must be performed on weeklies to of of tool
00:17:54
again it's important to generate and provide the result in less than one hour
00:17:59
because as soon as we know that the patient is positive isolation of
00:18:02
the patients and then after we can uh perform some additional test
00:18:07
to a complete the the the decision for the treatment but isolation the for the shoe
00:18:12
so for that we use on amplify the detection of touch can be
00:18:17
only by p. c. l. so what could have done in europe we want a very large
00:18:22
study in more than seven country we just use sounds and then five hundred samples
00:18:28
well this is the result so we we have tested our technology against different methods
00:18:34
g. d. f. w. in them that you just said was a billionaire
00:18:37
a a connection g. d. a. g. d. c. t. v. and unix protection the clutches of can we all of them
00:18:43
and the correlation we have with the reference methods when we compare without is ninety nine point two percent
00:18:50
so we can conclude that at this stage we have a very good test uh and clinical performance for our test
00:18:56
when you go country by country so you can see that we have performed when your country should someone
00:19:01
uh has it in specific c. t. are very hard that was compare was billy martin g.
00:19:06
h. unitary it's it's the same arrangement now than uh than france and u. k.
00:19:11
so the overall performance of uh i would have said if tested the it is in the very high
00:19:16
ranch you can see ninety five percent and close to a hundred percent plus does it does it
00:19:21
that is very important to have a very high sense basically city but you should not
00:19:26
need any positive you can have always of course false positive but the goal is
00:19:31
not to meet any positive and we are really better they another very important point also
00:19:37
due to the technology we use in the sequence you have in the fight
00:19:41
what people and user ace is to have no reason to be and because of
00:19:45
a failure of the system than many do trendy turning that one result
00:19:50
so we have a low uh we're under one two percent even one percent
00:19:55
uh and ways of and that thing that rate which is uh uh probably
00:19:58
one of the best also a a c. available today in the few
00:20:03
well with that system we witnessed thought that was the menu will continue to increase the
00:20:10
next test planning is a new for find a a on a finite is
00:20:15
that would be a step to a panel including except h. the to see and
00:20:20
stop the g. that will put their battery or property between craze that
00:20:25
the complexity of the test that no one telling after will be this year with the captain resistance until but uh yes
00:20:31
they with five uh resistant gene that would detect it b. c. oaks are in the and you know i mean
00:20:37
and also you can see that the with the panel with the test we
00:20:41
want to develop in the future most of them will be needed panel
00:20:45
and then with the with the part we can do that why because in the correct one we
00:20:50
can put the master needs for the time what one two three in the process control
00:20:54
the second one forty six on the process control and and so the want seven to nine the process control
00:21:00
the pitch once a laptop opinion resistance test would put k. p. c.
00:21:05
in the emphasis controller when one off of savvy meanwhile too
00:21:09
and that's something very important we ha the third wave available
00:21:14
and this is something very important because this is not a stable or status resistance
00:21:21
is always moving changing and we can expect that new gene we can't
00:21:26
and if there is a new one coming we don't need to redesign of a test
00:21:31
we just need to put that in the where available and we keep
00:21:34
the result as they do not have to perform another clinical studies
00:21:39
when i had the opportunity to present that technology to the c. d. c. there were very excited
00:21:44
because this is what they're looking for something open when they can put some eugene and test
00:21:49
what is the situation in the us and not compromising yeah the test because there's no company that
00:21:54
would compromise they're passing by having a new target that can these uh p. two more
00:21:59
so this is the power so of course with that we can do after whatever we want with a with a different band
00:22:07
now we have one machine doesn't mention we have the same protocol for the in it so we can
00:22:13
make different pairs point on the one one so limited investment and some new wanting an instrument
00:22:20
it's an emitted from k. e. o. 'cause it's only in one
00:22:25
and it's a very high i said lower or higher winds of uh
00:22:29
throughput from one sample or two sixty four sample but they
00:22:33
so if we compare was competition if we can one from one to sixty four
00:22:38
and competition depending on the one that will be able to perform
00:22:42
only with one instrument only up to a sixteen test today
00:22:47
so this is for the same price we have a machine that is
00:22:50
capable to do for five time but uh uh competitions capable to
00:22:55
some not why are we going with the point of care enough issues this is so this is a uh
00:23:02
something that the competition that has been published uh in the months ago
00:23:07
by i sent a cessation i'm a concession society for microbiology
00:23:12
and it can be the first time i've here implementation reunite clinic work flow
00:23:17
to incorporate near patient testing uh their patient point of k. testing
00:23:22
come out and then have to everything is going to that but i think this is the major information to do
00:23:28
so in the u. s. now they are changing completely the mine there yeah
00:23:33
moving in that direction to include would be the point of get testy
00:23:37
new routine day to day activities in every or speed than in every lap
00:23:42
is not something to try to to hide it something they want to develop and the we have a big
00:23:47
uh we have a very strong relation also is in the eye and they're very supportive with us
00:23:53
conclusion known subject there is already there upon the most are these with multiple critical difference encore
00:24:00
light variety of a biological sample as mentioned we can lead to rebut
00:24:05
we have the first product available uh in europe but also in the us
00:24:10
they approve many extensions so the next one will be struck panel base e. g. care
00:24:15
about up there we have stat stuff stuff already stuff it p. mechanic say
00:24:20
for maybe and much more our strengths is um you
00:24:25
simple the costs affordable multiplex up to twelve
00:24:29
uh fix immediately want to sixty four foot print very small connectivity
00:24:34
available ways we we can compare with the other one
00:24:38
and also we fulfil debris which you assured a requirement or my computer on the computer and is you can
00:24:45
add or yeah it is you want to chance that an idea on the product need some support
00:24:50
so i just want to say it again they go from our partner who is
00:24:53
with i think the first day and always reactive thank you uh how
00:25:07
ah
00:25:13
oh thank you
00:25:26
if
00:25:30
the infectious diseases can because that much more dentists twelve bacteria
00:25:36
so how do you want to know which bacterial causes detections disease
00:25:43
also and then you're kind of mortgage insulin resistance
00:25:48
i just wonder how you do it like have you seen any intentions to
00:25:52
increase the number of twelve two cats sixty two hundred or so
00:25:56
and it could question even spend the whole day just about the last phone and that's my for them not to do and it
00:26:02
uh this is a big discussion the v. beta one vibe into but they give you a quick a the the way we see that
00:26:08
uh i can tell you that that many years ago i was reading a project
00:26:12
isn't a few metric chip and i was able to detect or but
00:26:17
it was a disaster because we find or both everywhere in or patient so the the way hey we're in point of k.
00:26:24
the bottom from point of canned tests is to provide an answer in one hour actionable
00:26:28
so that's when it might be an easy translation of the what's inside the the the sample
00:26:34
we know that today with um the high a resolution panel available we know
00:26:40
for fun one time that we find multiple target in the sample
00:26:44
so it's so this it's it can be useful for some type of patient in i. c. u. r. e. o. emergency room
00:26:51
but it's surely not where you wanna go with our test is also we want
00:26:55
to lean it they're not just co of uh of uh uh the list
00:27:00
the back because when you see with uh for example twenty four but that on the list
00:27:05
if you go with the top eight uh that's it i would just hope
00:27:08
complete also that the us is also competed changing their mind with that
00:27:13
because uh the the these these very popular this time of test
00:27:18
and the us the the want to use that to eight to nine talk at the same time but not the big one
00:27:25
but that's a decision that we we can do to twenty four used to uh i used to pine free want
00:27:30
but uh do we see a uh an interest not for us also
00:27:35
but for the market probably not is not where we see that
00:27:39
that's that's a big the big thanks
Conference Program
Welcome Note
Gaëtan Cherix, Director - School of Engineering
Oct. 26, 2017 · 10:08 a.m.
210 views
Welcome Note
Marc E. Pfeifer, Symposium Chair
Oct. 26, 2017 · 10:15 a.m.
564 views
Point-of-care Diagnostics: what are the real needs of general practioners?
Nicolas Senn, PMU, UNIL
Oct. 26, 2017 · 10:19 a.m.
158 views
Recent developments in microtechnologies for point-of-care testing
Philippe Renaud, EPFL
Oct. 26, 2017 · 10:47 a.m.
217 views
GenePOC, a breakthrough solution in molecular point-of-care testing
Patrice Allibert, GenePOC
Oct. 26, 2017 · 11:19 a.m.
273 views
mHealth in the therapy follow-up of chronic inflammatory diseases – a smartphone based self-monitoring tool
Jakob Weber, BÜHLMANN Laboratories
Oct. 26, 2017 · 11:47 a.m.
104 views
Reglementary aspects ruling the reimbursement of laboratory analyses in the context of the compulsory health insurance
Michèle A. Fleury-Siegenthaler, Federal Office of Public Health
Oct. 26, 2017 · 2:12 p.m.
167 views
The applied research programme "Diagnostic Biochips": novel technologies for point-of-care diagnostics
Jean-Manuel Segura, HES-SO Valais
Oct. 26, 2017 · 2:42 p.m.
198 views
From brain proteomics discovery to the use of a POCT: The translation to mild traumatic brain injury (mTBI)
Jean-Charles Sanchez, CMU, UNIGE
Oct. 26, 2017 · 3:25 p.m.
472 views
Recent advances in non-invasive diagnostics
Samantha Paoletti, CSEM
Oct. 26, 2017 · 3:53 p.m.
199 views
How nanofluidics bring diagnostics closer to the patient
Fabien Rebeaud, Abionic
Oct. 26, 2017 · 4:17 p.m.
224 views
Keynote Session introduction
Marc E. Pfeifer, Symposium Chair
Oct. 26, 2017 · 5:07 p.m.
Keynote session: Accessible Bioanalysis for the Developing World and the Point of Care
George M. Whitesides, Harvard University, Cambridge - USA
Oct. 26, 2017 · 5:09 p.m.
230 views
Conclusions
Marc E. Pfeifer, Symposium Chair
Oct. 26, 2017 · 6:25 p.m.
Recommended talks
Airworthy AI; challenges of certification, part one
Dr. Luuk van Dijk, Founder and CEO of Daedalean
Oct. 12, 2018 · 2:05 p.m.
350 views
biospectal, the optical revolution in hypertension monitoring
Prof. Patrick Schoettker, CMO. Biospectal
June 15, 2018 · 2:06 p.m.
1004 views